Adia Nutrition Reports Over 200% Quarterly Revenue Growth and Advances Toward Nasdaq Listing

Reuters
2025/11/05
<a href="https://laohu8.com/S/ADIA">Adia Nutrition</a> Reports Over 200% Quarterly Revenue Growth and Advances Toward Nasdaq Listing

Adia Nutrition Inc. (OTCQB: ADIA) announced key business updates and financial results, highlighting significant growth and strategic progress in 2025. The company reported a revenue surge exceeding 200% quarter-over-quarter in the third quarter, with profit margins above 20%, attributed to strong demand for Adia Med clinics and Adia Labs regenerative products. Adia Nutrition has tripled its sales force and established four regional divisions to enhance nationwide and international distribution. The company also completed the divestiture of its non-core coffee subsidiary, Biolete Coffee, retaining an 18% equity stake. Additionally, Adia Nutrition is preparing to file its SEC Form 10 registration statement by the end of November 2025, aiming for full effectiveness by late January 2026 as part of its strategy to secure a Nasdaq listing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 273008) on November 05, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10